iCAD, Inc. (ICAD)
NASDAQ: ICAD · IEX Real-Time Price · USD
1.280
-0.040 (-3.03%)
Jul 26, 2024, 4:00 PM EDT - Market closed
iCAD, Inc. Revenue
iCAD, Inc. had revenue of $4.95M in the quarter ending March 31, 2024, with 14.31% growth. This brings the company's revenue in the last twelve months to $17.94M, up 7.98% year-over-year. In the year 2023, iCAD, Inc. had annual revenue of $17.32M, down -12.54%.
Revenue (ttm)
$17.94M
Revenue Growth
+7.98%
P/S Ratio
1.73
Revenue / Employee
$284,522
Employees
69
Market Cap
33.97M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 17.32M | -2.48M | -12.54% |
Dec 31, 2022 | 19.80M | -13.84M | -41.13% |
Dec 31, 2021 | 33.64M | 3.94M | 13.27% |
Dec 31, 2020 | 29.70M | -1.64M | -5.24% |
Dec 31, 2019 | 31.34M | 5.72M | 22.32% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CareCloud | 113.02M |
Exagen | 55.73M |
DarioHealth | 19.04M |
Cue Biopharma | 7.02M |
Lipocine | 4.71M |
IGC Pharma | 1.35M |
ICAD News
- 4 weeks ago - iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024 - GlobeNewsWire
- 7 weeks ago - iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference - GlobeNewsWire
- 2 months ago - iCAD Reports Financial Results for First Quarter Ended March 31, 2024 - GlobeNewsWire
- 2 months ago - UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024 - GlobeNewsWire
- 3 months ago - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024 - GlobeNewsWire
- 3 months ago - iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium - GlobeNewsWire
- 3 months ago - iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation - GlobeNewsWire
- 3 months ago - iCAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting - GlobeNewsWire